Thank you for Subscribing to Life Science Review Weekly Brief
×
Life Science Review Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review
Top 10 Genomics Solutions Companies in APAC – 2022
The rising demand for personalized medicine, increasing support from local governments via initiatives and public policies, and faltering costs of sequencing services are driving Asia-Pacific’s genomics market to record heights. This growth is also coupled with increasing partnerships among the key players in the market, who are aiming to expand their product portfolios, fostering their development and enhancing their global footprint. Governments in APAC are investing heavily in the implementation of several initiatives that promote the efficient development of genomics solutions. These solutions find application in a myriad of segments, such as diagnostics, precision medicine, drug development and delivery, animal research, and agriculture.
According to P&S Intelligence, the market will witness a stagging 12.7% CAGR between 2022 and 2030. In 2019 alone, APAC’s genomics market generated over 18 billion USD in revenue, which is expected to skyrocket to 68 billion by 2030. Owing to such significant growth and escalating utilization of high-throughput technologies, it is evident that APAC will continue to remain at the forefront of innovation in the global genomics firmament, enabling the life sciences community to enhance its offerings.
This edition of Life Sciences Review APAC lays the spotlight on the key developments in APAC’s genomics domain and how companies are leveraging contemporary technologies to mitigate the risks associated with mercurial market scenarios.
This edition also features thought leadership articles by Narayana Rao, Vice President of Biopharma APAC-MEA and Marianthi Psaha, Global Head of Cell and & Gene Therapy of Santen, sharing their views on how cell and gene therapy will lead the biomanufacturing industry and how leveraging contemporary technologies can improve gene therapy.
Along with that, the edition features innovative genomics solutions companies, including Genolution, OPTOLANE Technologies, and Zinexts. These companies offer groundbreaking genomics solutions, helping APAC’s life science industry navigate the myriad of challenges associated with molecular biology, clinical research, drug development, and disease diagnostics.
We present to you the “Top 10 Genomics Solution Providers in APAC - 2022.
Nominate a Company
Our subscribers nominate the companies with whom they have collaborated and gotten results. If you think there is a company that deserves to be on our upcoming prestigious annual list of Top 10 Genomics Solutions Companies in APAC – 2022 , please write to us about them and the reasons you think they need to be on the list
-
Established in 2006, Genolution Inc. has been providing solutions toward a better life by focusing on the fields of molecular diagnostics and RNAi. The results of Genolution’s efforts and longstanding experience in the field are now presented to the world in the form of Nextractor, the company’s flagship offering. The Nextractor instrument a name suffixed to a series of devices plays a vital role in supporting downstream genomics processes, extracting nucleic acid in its purest state from various sample types such as blood, saliva, or tissue. The chemistry of Genolution’s reagent further improves the yield quality, directly affecting the downstream applications in next-generation sequencing (NGS) and polymerase chain reaction (PCR) testing.
We believe that our fast, robust, and affordable products can provide researchers with the benefits they need to improve their genomic service
—Gi-Ok Kim, CEO
-
OPTOLANE offers a POCT diagnostic platform for disease diagnosis and preventive home healthcare market. OPTOLANE Technologies, an innovator in the healthcare and diagnostics industry, has designed a platform that gives them direct contact with customers and helps them develop strategies for solutions. The diagnostic platform enables them to receive samples easily and perform genome sequencing as they concurrently create and correlate epigenetic situation data with customers to extract health check factors suitable for every situation. With the technology to develop diagnostic panels and the data to build more precise correlations, the company is designing a self-diagnosis system, as well as diagnostic items that can be used at home.
Do Young Lee, CEOThe Digital Real Time PCR can perform much better and has improved usability over the Real Time qPCR
-
Zinexts Life Science is a leading biotechnology company designing, developing, and manufacturing molecular biology laboratory solutions for clinical diagnosis, lifesciences, and research.
One of our core capabilities is to design and innovate reliable automation for DNA and RNA extraction from any biological sample
—Hartmut Goette, VP Commercial Operations
-
Genomedia hails from Tokyo, Japan, and has been providing services and tools for genomic information analysis to medical research experts
Genomedia have been providing services and tools for genomic information analysis to medical research experts
—Mahoto Mugita, Project Manager
-
Berry Genomics
Berry Genomics is a leading company in clinical genomics and life science in China. This firm aims to assist accurate diagnosis of diseases throughout the full human life circle, and to improve human health
-
First Dimension
First Dimension is a company working on quantifying life with big data genomics. Their mission is to utilize genomic information to improve public health
First Dimension
Management
.
Genomics Solutionss in APAC – 2022 by First Dimension :
- .
-
Genetic Technologies(GTG: ASX)
Genetic Technologies is a World Leader in Genetic Risk Assessment. Their brand geneType offers integrated risk testing for a range of serious conditions
-
Lab Genomics
LabGenomics is a healthcare company specialized on molecular diagnostics grown up in the market through developemt of new effective diagnostic methods various kinds of diseases
-
Nippon Gene
Nippon Gene develops and manufactures tools for life science research and sells them to research institutes
-
Takara Bio(TYO: 4974)
Takara Bio contributes to the health of humankind through the development of revolutionary biotechnologies such as gene therapy
